These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2458511

  • 41. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.
    Hefti F, Enz A, Melamed E.
    Neuropharmacology; 1985 Jan; 24(1):19-23. PubMed ID: 2858830
    [Abstract] [Full Text] [Related]

  • 42. Tolerance develops to the haloperidol-induced increase in the efflux of dopamine metabolites from the brains of unanesthetized, freely-moving rats.
    Nielsen JA, Duda NJ, Moore KE.
    Life Sci; 1982 Oct 04; 31(14):1495-1500. PubMed ID: 6183554
    [Abstract] [Full Text] [Related]

  • 43. Effect of alpha-methyl fluorodopa on dopamine metabolites: importance of conjugation and egress.
    Sarna GS, Hutson PH, Curzon G.
    Eur J Pharmacol; 1984 May 04; 100(3-4):343-50. PubMed ID: 6203763
    [Abstract] [Full Text] [Related]

  • 44. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S, Herregodts P, Deleu D, Devrieze A, De Klippel N, Ebinger G, Michotte Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep 04; 346(3):277-85. PubMed ID: 1407014
    [Abstract] [Full Text] [Related]

  • 45. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ.
    Eur J Pharmacol; 1976 Sep 04; 39(1):33-40. PubMed ID: 964303
    [Abstract] [Full Text] [Related]

  • 46. Monoamine acid metabolites in ventricular CSF of patients with brain tumours.
    Bareggi SR, Porta M, Collice M, Calderini G, Ferrara M, Morselli PL.
    Acta Neurochir (Wien); 1976 Sep 04; 35(1-3):161-70. PubMed ID: 961500
    [Abstract] [Full Text] [Related]

  • 47. Comparative analysis of indices of central dopaminergic functions in man.
    Bagdy G, Arató M, Baraczka K, Fekete MI.
    Life Sci; 1983 Jun 06; 32(23):2667-76. PubMed ID: 6855463
    [Abstract] [Full Text] [Related]

  • 48. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
    Vaughn DM, Smyth GB, Whitmer WL, Satjawatcharaphong C.
    Vet Res Commun; 1989 Jun 06; 13(3):237-49. PubMed ID: 2476887
    [Abstract] [Full Text] [Related]

  • 49. Determination of daily variations of brain 5-hydroxytryptamine and dopamine turnovers and of the clearance of their acidic metabolites in conscious rats by repeated sampling of cerebrospinal fluid.
    Hutson PH, Sarna GS, Curzon G.
    J Neurochem; 1984 Jul 06; 43(1):291-3. PubMed ID: 6202845
    [Abstract] [Full Text] [Related]

  • 50. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size.
    Castañeda E, Whishaw IQ, Robinson TE.
    J Neurosci; 1990 Jun 06; 10(6):1847-54. PubMed ID: 1693953
    [Abstract] [Full Text] [Related]

  • 51. The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.
    Ebinger G, Michotte Y, Herregodts P.
    J Neurochem; 1987 Jun 06; 48(6):1725-9. PubMed ID: 3572399
    [Abstract] [Full Text] [Related]

  • 52. Dynamic regulation of striatal dopaminergic grafts during locomotor activity.
    Hattori S, Hashitani T, Matsui N, Nishino H.
    Brain Res; 1996 Feb 26; 710(1-2):45-55. PubMed ID: 8963678
    [Abstract] [Full Text] [Related]

  • 53. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep 26; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 54. Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration.
    Cohen DJ, Shaywitz BA, Caparulo B, Young JG, Bowers MB.
    Arch Gen Psychiatry; 1978 Feb 26; 35(2):245-50. PubMed ID: 272137
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats.
    Altar CA, O'Neil S, Marshall JF.
    Neuropharmacology; 1984 Mar 26; 23(3):309-18. PubMed ID: 6427648
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum.
    Zis AP, Nomikos GG, Damsma G, Fibiger HC.
    Psychopharmacology (Berl); 1991 Mar 26; 103(3):343-50. PubMed ID: 1711702
    [Abstract] [Full Text] [Related]

  • 59. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C, Slevin JT.
    Synapse; 1989 Mar 26; 4(3):248-53. PubMed ID: 2532792
    [Abstract] [Full Text] [Related]

  • 60. Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma.
    Emanuelsson BM, Widerlöv E, Walléus H, Paalzow LK.
    Psychopharmacology (Berl); 1987 Mar 26; 92(2):144-9. PubMed ID: 2440072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.